|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 283, Issue 4, 1974-1984, January 25, 2008
Signaling by the Cysteinyl-Leukotriene Receptor 2INVOLVEMENT IN CHEMOKINE GENE TRANSCRIPTION*![]() ![]() ![]() ![]() ![]() ![]() ![]() 1
From the
Cysteinyl-leukotrienes are involved in inflammation and act on at least two G-protein-coupled receptors, CysLT1 and CysLT2. However, the role of the CysLT2 receptor as well as its signaling remain poorly understood. Here we show that leukotriene (LT)C4 induced the production of the chemokine interleukin (IL)-8 in endothelial cells. To further study the signaling cascade involved, HEK293 cells were stably transfected with CysLT2 and used to study the transcriptional regulation of the IL-8 promoter. Stimulation of the cells with increasing concentrations of LTC4 resulted in a time- and concentration-dependent induction of IL-8 transcription and protein synthesis. Use of IL-8 promoter mutants with substitutions in their NF-
Received for publication, August 25, 2006 , and in revised form, November 18, 2007. * This work was supported in part by grants (to P. P. McD., J. S., and M. R.-P.) and studentships (to C. T., A. C., and Y. B.) from the Canadian Institutes of Health Research and a grant from the Foundation for Research into Children's Diseases. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Recipient of a Canada Research Chair in Inflammation. To whom correspondence should be addressed: 3001 North 12th Ave., Sherbrooke, Quebec J1H 5N4, Canada. Tel.: 819-346-1110 (ext: 14851); Fax: 819-564-5215; E-mail: marek.rola-pleszczynski{at}usherbrooke.ca.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||